Bruce Polsky - 20 Jun 2024 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Bruce Polsky
Issuer symbol
AVIR
Transactions as of
20 Jun 2024
Net transactions value
-$61,144
Form type
4
Filing time
21 Jun 2024, 17:59:55 UTC
Previous filing
18 Jun 2024
Next filing
24 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Bruce Polsky filed Form 4 for Atea Pharmaceuticals, Inc. (AVIR) on 21 Jun 2024."

Quick Takeaways

  • This page summarizes Bruce Polsky's Form 4 filing for Atea Pharmaceuticals, Inc. (AVIR).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Filing timestamp: 21 Jun 2024, 17:59.

What Changed

  • Previous filing in this sequence was filed on 18 Jun 2024.
  • Current net transaction value: -$61,144.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVIR Common Stock Sale $61,144 -17,544 -21% $3.49 65,606 20 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Restricted Stock Units Award $0 +29,600 $0.000000 29,600 21 Jun 2024 Common Stock 29,600 Direct F2, F3
transaction AVIR Stock Option (Right to Buy) Award $0 +41,200 $0.000000 41,200 21 Jun 2024 Common Stock 41,200 $3.44 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to cover taxes upon the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.53, inclusive.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
F4 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.

Sponsored